Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Glutathione peroxidase (GPx) and superoxide dismutase (SOD) activity in patients with diabetes mellitus type 2 infected with Epstein-Barr virus

  • Jakub Dworzański,

    Roles Conceptualization, Data curation, Investigation, Resources, Writing – original draft

    Affiliation Masovian Specialist Hospital, Radom, Poland

    ⨯
  • Małgorzata Strycharz-Dudziak,

    Roles Data curation, Writing – original draft, Writing – review & editing

    Affiliation Chair and Department of Conservative Dentistry with Endodontics, Medical University of Lublin, Lublin, Poland

    ⨯
  • Ewa Kliszczewska ,

    Roles Formal analysis, Methodology, Visualization

    ewakliszczewska@gmail.com

    Affiliation Department of Virology, Medical University of Lublin, Lublin, Poland

    ⨯
  • Małgorzata Kiełczykowska,

    Roles Methodology

    Affiliation Department of Medical Chemistry, Medical University of Lublin, Lublin, Poland

    ⨯
  • Anna Dworzańska,

    Roles Data curation, Resources, Visualization

    Affiliation Masovian Specialist Hospital, Radom, Poland

    ⨯
  • Bartłomiej Drop,

    Roles Software

    Affiliation Department of Information Technology and Medical Statistics, Medical University of Lublin, Lublin, Poland

    ⨯
  • Małgorzata Polz-Dacewicz

    Roles Conceptualization, Funding acquisition, Project administration, Supervision, Visualization, Writing – review & editing

    Affiliation Department of Virology, Medical University of Lublin, Lublin, Poland

    ⨯

Abstract

Oxidative stress is suggested to be the crucial factor in diabetes mellitus type 2 (DM2) pathogenesis and in the development of diabetic complications. Patients with DM2 may be more susceptible to infections due to hyperglycaemia-induced virulence of various microorganisms. Several studies pointed that Epstein-Barr virus (EBV) infection is associated with reactive oxygen species (ROS) production and/or activation of signalling pathways connected with ROS. The present study analyzed serum activity of glutathione peroxidase (GPx) and superoxide dismutase (SOD) in DM2 patients with and without EBV infection. Blood and saliva were collected from 120 patients with DM2. EBV DNA was detected in the saliva using nested-PCR technique. Spectrophotometric methods were implemented to determine serum GPx and SOD activity with the use of diagnostic kits produced by Randox Laboratories. GPx and SOD activity was decreased in diabetic patients, with the lowest values in DM2 EBV-positive patients. There was correlation between GPx and SOD activity–with increased value of GPx, SOD activity was also rised. In patients with DM2 history longer than 10 years as well as in DM2 patients with obesity, antioxidant enzymes activity was decreased. Determination of examined parameters may be useful in diabetic patients with EBV infection and could be important prognostic factor.

Citation: Dworzański J, Strycharz-Dudziak M, Kliszczewska E, Kiełczykowska M, Dworzańska A, Drop B, et al. (2020) Glutathione peroxidase (GPx) and superoxide dismutase (SOD) activity in patients with diabetes mellitus type 2 infected with Epstein-Barr virus. PLoS ONE 15(3): e0230374. https://doi.org/10.1371/journal.pone.0230374

Editor: Joseph S. Pagano, University of North Carolina at Chapel Hill, UNITED STATES

Received: December 2, 2019; Accepted: February 27, 2020; Published: March 25, 2020

Copyright: © 2020 Dworzański et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: All relevant data are within the paper.

Funding: This study was supported by a Research Grant from the Medical University of Lublin, Lublin, Poland (DS 233)

Competing interests: The authors have declared that no competing interests exist.

Introduction

Diabetes mellitus type 2 (DM2) has become one of the most important global health problems recently. It reaches epidemic proportions as in the year 2015 there were nearly 415 million people with diagnosed DM2 and by the year 2040 this number is expected to increase to 642 million [1,2].

Many reports suggest that oxidative stress is implicated in the pathogenesis of DM2 [3–6]. There are three major enzymes in antioxidant defense system: glutathione peroxidase (GPx), superoxide dismutase (SOD), and catalase (CAT) [7–8].

Epstein-Barr virus (EBV) is widespread human virus belonging to Herpesviridae family—more than 90% of adults are EBV-seropositive worldwide. As the first known human carcinogenic virus it is associated with various malignancies, such as Hodgkin's lymphomas (HL), Burkitt's lymphomas (BL), nasopharyngeal cancer (NPC) and gastric cancer (GC) [9]. EBV may establish a persistent infection and reactivate periodically into the lytic cycle which has impact on the pathogenesis of EBV-associated tumours [10–12]. According to some researches, patients with diabetes mellitus type 2 are more susceptible to infections due to hyperglycaemia-induced virulence of various microorganisms [13]. Other studies pointed that infection with EBV is associated with reactive oxygen species (ROS) production and/or with activation of signalling pathways connected with ROS [14,15].

Our previous research revealed that the prevalence of EBV DNA in patients with diabetes is significantly higher than in individuals without this disease [16]. The present study analyzed the serum activity of GPx and SOD in the patients with DM2 with and without EBV infection.

Materials and methods

Patients

The present study involved 120 patients with diabetes mellitus type 2 hospitalized at the Internal Division of the Masovian Specialist Hospital in Radom, Poland. The control group comprised 50 individuals without diabetes (patients treated at the same department due to other diseases than DM2) suitably selected in terms of sex, age, place of residence, smoking and alcohol consumption. All persons from the control group were EBV negative. In terms of socio-demographic features, smoking and alcohol consumption these groups did not differ and therefore the features did not affect the values of examined parameters.

The study was approved by the Medical University of Lublin Ethics Committee, and is in accordance with the GCP regulations (No. KE-0254/135/2017, 25 May 2017). Informed written consent was collected from all participants.

Clinical specimens

Blood and saliva were collected from the patients and controls. EBV DNA was detected in the saliva. Oxidant parameters were detected in serum.

Saliva collection.

About 5 ml of non-stimulated whole saliva was collected. The saliva samples were centrifuged at 1500 rpm at room temperature for 10 min, and then diluted (1:1) in PBS and frozen at -80°C until their analysis.

Serum collection.

Venous blood samples from both the patients and the controls were centrifuged at 1500 rpm at room temperature for 15 min, followed by serum collection and frozen at -80°C until its analysis.

Molecular methods

DNA extraction from saliva.

DNA isolation was performed using the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. The efficiency and purity of the obtained eluate were checked using the Epoch (Biotek) spectrophotometer. The measurement was performed on a Take 3 plate (Biotek Instruments, Winooski, Vermont, US) using Microplate Reader Software Gen 5.2.0 (Biotek Instruments, Winooski, Vermont, US).

EBV DNA detection.

EBV DNA detection and the amplification of the Epstein–Barr nuclear antigen 2 (EBNA-2) gene (the nested PCR) were performed as previously described [17]. The nested PCR was carried out for amplification of Epstein-Barr nuclear antigen 2 (EBNA-2). The sequence of primers used for PCR was as follows: outer pair 5’–TTT CAC CAA TAC ATG ACC C– 3’, 5’–TGG CAA AGT GCT GAG AGC AA– 3’ and inner pair 5’–CAA TAC ATG AAC CRG AGT CC– 3’, 5’–AAG TGC TGA GAG CAA GGC MC– 3’.

All PCR reactions were carried out in the final volume of 25 μl using HotStartTaq DNA Polymerase (Qiagen, Germany). Concentrations of PCR reaction components were prepared as follows: 2.0 mM MgCl2, 0.2 mMdNTPs, 0.5 μM of each forward and reverse primers and 0.5 U of HotStartTaq polymerase. During each run the samples were tested together with one negative (nuclease-free water) and positive control (EBV-positive cell line, Namalwa, ATCC-CRL-1432) [18].

Oxidant parameters.

SOD activity was determined using diagnostic kit RANSOD produced by RANDOX (Randox Laboratories Ltd., Crumlin, Country Antrim, UK) according to Arthur and Boyne [19] and expressed in U of SOD/10mgof protein.

GPx activity was determined using diagnostic kit RANSEL produced by RANDOX (Randox Laboratories Ltd., Crumlin, Country Antrim, UK) according to Paglia and Valentine [20] and expressed in U of GPx/mg of protein. Protein was measured using method of Bradford [21]. The assays were performed with the use of spectrophotometer SPECORD M40 (Carl Zeiss, Jena, Germany).

Statistical analysis

Statistical analysis was performed using Pearson’s chi-square test, Fisher’s exact test for small groups, ANOVA Kruskal-Wallis test with post-hoc Dunn`s test and Spearman`s Rank Test. The statistical significance was defined as p < 0.05.

Results

Clinical and epidemiological characteristics of the patients is presented in Table 1.

thumbnail
Download:
Table 1. Epidemiological characteristics of EBV-positive and EBV-negative diabetic patients.

https://doi.org/10.1371/journal.pone.0230374.t001

GPx and SOD activity in the serum of patients with DM2 was statistically lower than in control group. Statistically significant differences were stated in GPx and SOD activity in EBV-positive and EBV-negative patients (Figs 1 and 2). Both analysed parameters had the lowest activity in EBV-positive patients (GPx = 5.18±2.19, SOD = 0.88±0.45) and the highest in the control group (GPx = 17.23 ± 1.34, SOD = 2.68±0.14).

thumbnail
Download:
Fig 1. Serum activity of GPx in EBV-positive, EBV-negative diabetic patients and control group.

ANOVA Kruskal-Wallis Test (H = 128.22; p < 0.0001); Post-hoc Dunn’s Test: EBV+/EBV-p< 0.0001; EBV+/Control p< 0.0001; EBV-/Control p< 0.0001.

https://doi.org/10.1371/journal.pone.0230374.g001

thumbnail
Download:
Fig 2. Serum activity of SOD in EBV-positive, EBV-negative diabetic patients and control group.

ANOVA Kruskal-Wallis Test (H = 126.92; p < 0.0001; Post-hoc Dunn’s Test: EBV+/EBV- p< 0.0001; EBV+/Control p< 0.0001; EBV-/Control p< 0.0001.

https://doi.org/10.1371/journal.pone.0230374.g002

Fig 3 shows correlation between serum activity of GPx and SOD in EBV-positive diabetic patients. With increased activity of GPx there was also increase in the activity of SOD.

thumbnail
Download:
Fig 3. Correlation between GPx and SOD activity in EBV-positive diabetic patients.

Spearman’s Rank Test (R = 0.7784; p < 0.0001).

https://doi.org/10.1371/journal.pone.0230374.g003

Activity of antioxidant enzymes depended on the duration of diabetes and BMI index (Table 2). Activity of both GPx and SOD were significantly lower in patients with a DM2 history longer than 10 years (GPx = 3.10; SOD = 0.43) and in diabetic patients with obesity (GPx = 3.10; SOD = 0.43).

thumbnail
Download:
Table 2. GPx (U/mg of protein) and SOD (U/10mg of protein) activity according to duration of diabetes and BMI in EBV-positive diabetic patients.

https://doi.org/10.1371/journal.pone.0230374.t002

Discussion

According to various studies oxidative stress is the crucial factor in DM2 pathogenesis as well as in the development of diabetic complications [3,5,22,23].

Although diabetes is associated with an increased production of ROS, the reports about the antioxidant defense in diabetes are not conclusive. Our study revealed decreased activity of GPx and SOD in patients with DM2 in comparison with control group. These findings are in agreement with other researches outcomes [5,8,24–28]. Lowered activity of these enzymes might be explained by the depletion of antioxidant defense system following the overgeneration of free radicals [29,30]. In diabetic patients glucose autooxidation results in formation of hydrogen peroxide which inactivates SOD. Accumulation of hydrogen peroxide may be one of the explanations for decreased activity of this enzyme [28]. GPx in normal conditions is a relatively stable enzyme, while in severe oxidative stress conditions it may be inactivated. Additionally, high glucose condition may cause inactivation of this enzyme by its glycation [28]. Moreover, hyperglycaemia and overproduction of ROS depress the endogenous antioxidant system and expose cells to damage due to oxidative stress which can initiate diabetic complications [23].

Some studies demonstrated, however, increase in SOD and GPx activity in patients with DM when compared with controls, despite the presence of oxidative stress [31,32]. Al-Rawi [33] reported increased activity of SOD both in saliva and in serum of patients with DM2, while Aouacheri et al. [34] revealed increase in SOD value with lowered GPx activity in diabetic patients. Decreased activity of these enzymes was also stated in our study in patients with longer duration of the disease. It is in line with the results obtained by Briggs et al. [8], as they revealed significant decrease in the level of antioxidant enzymes level with increasing years of the disease.

Singh et al. [28], who performed studies in diabetic patients with and without complications, reported the highest SOD and GPx activity in non-diabetic individuals, lower in diabetic patients without complication and the lowest in DM2 patients with complications. Analysis of antioxidant enzymes activity in DM2 diabetic patients regarding EBV infection carried out in our study revealed a similar tendency–the values of GPx and SOD was the highest in the individuals without diabetes, lower in EBV(-) patients and the lowest in EBV(+) patients. According to our researches both EBV infection and diabetes are associated with lower values of antioxidant enzymes.

Our previous studies revealed that EBV DNA was detected more frequently in the group of diabetic patients (35.9%) than in patients without diabetes [16]. Chronic infections caused by various viruses influence the whole immunity of the patient. However, there are few reports in the literature about the relationship between DM2 and viral infections. EBV is also a proven risk factor for various malignancies, but no studies evaluating the relationships between viral infection, oxidative stress and diabetes are available. Some researches point to connection between infection with EBV and oxidative stress, especially in EBV(+) tumours [35]. It was demonstrated that oxidative stress and factors leading to DNA damage induce the expression of EBV lytic genes. As it was also suggested, the virus in the process of EBV reactivation encodes several anti-apoptotic proteins, which may inhibit apoptosis. Therefore, reactivation of EBV is a substantial risk factor for disease related to EBV [36].

There are reports about malignancies developing more frequently in diabetic patients, especially in individuals with DM2 [37]. Our previous study revealed that in cancer patients with EBV infection there was decrease in the value of antioxidant enzymes [38]. The present research showed that in diabetic patients infected with EBV the activity of SOD and GPx was also lowered. As EBV is a proven oncogenic virus, diabetic patients infected with EBV may be at higher risk of development of malignant diseases. In our research only 6% of diabetic patients were diagnosed with cancer, so the group was too small for statistical analysis, but this matter may be the subject of our future studies. Determination of these parameters may be useful in EBV(+) DM2 patients and could be an important prognostic factor as well as a marker of diabetic complications.

Conclusions

Activity of SOD and GPx was decreased in diabetic patients, with the lowest values in EBV(+) patients with DM2. There was correlation between GPx and SOD activity–with increased activity of GPx there was also increase in the activity of SOD. In patients with DM2 history longer than 10 years and obesity, the activity of antioxidant enzymes was decreased.

References

  1. 1. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017; 128:40–50. pmid:28437734
  2. 2. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014; 103:137–49. pmid:24630390
  3. 3. Burgos-Morón E, Abad-Jiménez Z, Marañón AM, Iannantuoni F, Escribano-López I, López-Domènech S, et al. Relationship Between Oxidative Stress, ER Stress, and Inflammation in Type 2 Diabetes: The Battle Continues. J Clin Med. 2019; 8:E1385. pmid:31487953
  4. 4. Chikezie PC, Ojiako OA, Ogbuji AC. Oxidative stress in diabetes mellitus. Integr Obes Diabetes. 2015; 1:71–79.
  5. 5. Bikkad MD, Somwanshi SD, Ghuge SH, Nagane NS. Oxidative Stress in Type II Diabetes Mellitus. Biomed Res. 2014; 25:84–87.
  6. 6. Ma X, Chen Z, Wang Le, Wang G, Wang Z, Dong XB, et al. The Pathogenesis of Diabetes Mellitus by Oxidative Stress and Inflammation: Its Inhibition by Berberine. Front Pharmacol. 2018; 9:782. pmid:30100874
  7. 7. Manoharan S, Kolanjiappan K, Suresh K, Panjamurthy K. Lipid peroxidation and antioxidants status in patients with oral squamous cell carcinoma. Indian J Med Res. 2005; 122:529–534. pmid:16518005
  8. 8. Briggs ON, Brown H, Elechiamadi K, Ezeiruaku F, Nduka N. Superoxide Dismutase and Glutathione Peroxidase Levels in Patients with Long Standing Type2 Diabetes in Port Harcourt, Rivers State, Nigeria. Int J Sci Res (Online). 2016; 5:2319–7064.
  9. 9. Parker MT. An Ecological Framework of the Human Virome Provides Classification of Current Knowledge and Identifies Areas of Forthcoming Discovery. Yale J Biol Med. 2016; 89:339–351. pmid:27698618
  10. 10. Handley SA. The virome: a missing component of biological interaction networks in health and disease. Genome Med. 2016; 8:5.
  11. 11. Houghton D, Hardy T, Stewart C, Errington L, Day CP, Trenell MI, et al. Systematic review assessing the effectiveness of dietary intervention on gut microbiota in adults with type 2 diabetes. Diabetologia. 2018; 61:1700–1711. pmid:29754286
  12. 12. Nikolich-Zugich J, Goodrum F, Knox K, Smithey MJ. Known unknowns: how might the persistent herpesvirome shape immunity and aging?. Curr Opin Immunol. 2017; 48:23–30. pmid:28780492
  13. 13. Casquiero J, Casquiero J, Alves C. Infections in patients with diabete mellitus; A review of pathogenesis. Indian J Endocrinol Metab. 2012; 1:S27–36.
  14. 14. Gargouri B, Nasr R, ben Mansour R, Lassoued S. Reactive oxygen species production and antioxidant enzyme expression after Epstein-Barr virus lytic cycle induction in Raji cell line. Biol Trace Elem Res. 2011; 144:1449–1457. pmid:21792596
  15. 15. Hu J, Li H, Luo X, Li Y, Bode A, Cao Y. The role of oxidative stress in EBV lytic reactivation, radioresistance and the potential preventive and therapeutic implications. Int J Cancer. 2017; 141:1722–1729. pmid:28571118
  16. 16. Dworzański J, Drop B, Kliszczewska E, Strycharz-Dudziak M, Polz-Dacewicz M. Prevalence of Epstein-Barr virus, human papillomavirus, cytomegalovirus and herpes simplex virus type 1 in patients with diabetes mellitus type 2 in south-eastern Poland. PLoS ONE. 2019; 14:e0222607. pmid:31550259
  17. 17. Polz-Dacewicz M, Strycharz-Dudziak M, Dworzanski J, Stec A, Kocot J. Salivary and serum IL-10, TNF-α, TGF-β, VEGF levels in oropharyngeal squamous cell carcinoma and correlation with HPV and EBV infection. Infect Agent Cancer. 2016; 11:45. pmid:27547238
  18. 18. Foltyn S, Strycharz-Dudziak M, Drop B, Boguszewska A, Polz-Dacewicz M. Serum EBV antibodies and LMP-1in Polish patients with oropharyngeal and laryngeal cancer. Infect Agents Cancer. 2017; 12:31. pmid:28572837
  19. 19. Arthur JR, Boyne R. Superoxide dismutase and glutathione peroxidase activities in neutrophils from selenium deficient and copper deficient cattle. Life Sci. 1985; 36:1569–1575. pmid:3982227
  20. 20. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidise. J Lab Clin Med. 1967; 70:158–169. pmid:6066618
  21. 21. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein tilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248–254. pmid:942051
  22. 22. Al Hrooba AM, Abukhalilb MH, Husseinc OE, Mahmoudc AM. Pathophysiological mechanisms of diabetic cardiomyopathy and the therapeutic potential of epigallocatechin-3-gallate. Biomed Pharmacother. 2019; 109:2155–2172. pmid:30551473
  23. 23. Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010; 107:1058–1070. pmid:21030723
  24. 24. Gawlik K, Naskalski JW, Fedak D, Pawlica-Gosiewska D, Grudzień U, Dumnicka P, et al. Markers of Antioxidant Defense in Patients with Type 2 Diabetes. Oxid Med Cell Longev. 2016; 2016:2352361. pmid:26640613
  25. 25. Ramakrishna V, Jailkhani R. Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients. Acta Diabetol. 2008; 45:41–6. pmid:17924055
  26. 26. Hisalkar PJ, Patne AB, Fawade MM, Karnik AC. Evaluation of plasma superoxide dismutaseand glutathione peroxidase in type 2 diabetic patients. Biol Med. 2012; 4:65–72.
  27. 27. Kumawat M, Pahwa MB, Gahlaut VS, Singh N. Status of Antioxidant Enzymes and Lipid Peroxidation in Type 2 Diabetes Mellitus with Micro Vascular Complications. The Open Endocrinology Journal. 2009;3:12–15.
  28. 28. Singh SR, Hijam D, Dubey A, Devi NO, Jamir S, Longkumer C, et al. Study Of Oxidative Stress Status In Type 2 Diabetic Patients. Int J Cont Med Res. 2015; 2:20–26.
  29. 29. Manasaveena V, Akula KK, Sangram V. A comparative evaluation of enzymatic antioxidant levels in pre and post therapy patients with oral cancer. Int J Pharm Pharm Sci. 2014; 6:52–56.
  30. 30. Singh AK, Pandey P, Tewari M, Pandey HP, Gambhir IS, Shukla HS. Free radicals hasten head and neck cancer risk: a study of total oxidant, total antioxidant, DNA damage, and histological grade. J Postgrad Med. 2016; 62:96–101. pmid:27089108
  31. 31. Bandeira Sde M, Guedes Gda S, da Fonseca LJ, Pires AS, Gelain DP, Moreira JC, et al. Characterization of blood oxidative stress in type 2 diabetes mellitus patients: increase in lipid peroxidation and SOD activity. Oxid Med Cell Longev. 2012; 2012:819310. pmid:23259029
  32. 32. Moussa SA. Oxidative stress in diabetes mellitus. Romanian Biophys. 2008; 18:225–236.
  33. 33. Al-Rawi NH. Oxidative stress, antioxidant status and lipid profile in the saliva of type 2 diabetics. Diab Vasc Dis Res. 2011; 8:22–8. pmid:21262867
  34. 34. Aouacheri O, Saka S, Krim M, Messaadia A, Maidi I. The Investigation of the Oxidative Stress-Related Parameters in Type 2 Diabetes Mellitus. Can J Diabetes. 2015; 39:44–49. pmid:25065473
  35. 35. Lassoued S, Ben Ameur R, Ayadi W, Gargouri B, Mansour RB, Attia H. Epstein-Barr virus induces an oxidative stress during the early stages of infection in B lymphocytes, epithelial, and lymphoblastoid cell lines. Mol Cell Bioche. 2008; 313:179–186.
  36. 36. Arvey A, Tempera I, Tsai K, Chen HS, Tikhmyanova N, Klichinsky M, et al. An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions. Cell Host Microbe. 2012; 12:233–245. pmid:22901543
  37. 37. Giovanuci E, Harlen DM, Archer MC, Bergenstal RM, Gapstur SM, Habel L, et al. Diabetes and cancer. A consensus report. Diabetes Care. 2010; 33:1674–1685. pmid:20587728
  38. 38. Strycharz-Dudziak M, Kiełczykowska M, Drop B, Świątek Ł, Kliszczewska E, Musik I, et al. Total Antioxidant Status (TAS), Superoxide Dismutase (SOD), and Glutathione Peroxidase (GPx) in Oropharyngeal Cancer Associated with EBV Infection. Oxid Med Cell Longev. 2019; 2019:5832410. pmid:31360295